Sandoz

Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
BioSpace
Tue, 03/3/20 - 10:55 am
Sandoz
generics
Novartis
antitrust
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Fierce Pharma
Thu, 02/27/20 - 10:39 am
Sandoz
generics
antibiotics
COVID-19
coronaviruses
Former Novartis exec pleads guilty to generic price fixing
Endpoints
Tue, 02/18/20 - 10:25 am
Novartis
Sandoz
price fixing
generics
DOJ
Sandoz Completes Acquisition of Aspen's Japanese Operations
BioSpace
Sat, 02/1/20 - 11:49 pm
Sandoz
Aspen Global
Japan
M&A
Novartis
Novartis' Sandoz loses bid to break United Therapeutics' exclusive device deal for Remodulin
Fierce Pharma
Thu, 01/30/20 - 09:17 pm
Novartis
Sandoz
United Therapeutics
Remodulin
Novartis' Generics Unit to Buy Aspen's Japanese Operations
Yahoo/Zacks.com
Mon, 11/11/19 - 10:47 am
Novartis
generics
Sandoz
M&A
Japan
Aspen Pharmacare
Aspen Global
Novartis takes a step back from marketing Pear prescription digital therapeutics
Biopharma Dive
Wed, 10/16/19 - 06:57 pm
Novartis
Sandoz
Pear Therapeutics
digital therapeutics
opioid abuse
Why Bausch Health Companies Stock Sank Today
Motley Fool
Tue, 10/1/19 - 11:01 pm
Bausch Health
Novartis
Sandoz
Xifaxan
patents
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
Pharmaforum
Tue, 09/3/19 - 10:30 am
Novartis
Sandoz
generics
biosimilars
Tysabri
Polpharma
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Novartis
Sandoz
biosimilars
Amgen
Enbrel
patents
Erelzi
Enbrel ruling lifts Amgen shares
BioCentury
Sat, 08/10/19 - 02:02 pm
Amgen
Enbrel
patents
Sandoz
generics
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Tue, 07/23/19 - 10:03 am
Novartis
Sandoz
biosimilars
clinical trials
denosumab
osteoporosis
Prolia
Xgeva
Novartis’ sunny Sandoz forecast is at odds with the reality of the US generics market: analysts
Fierce Pharma
Fri, 07/19/19 - 10:47 am
Novartis
generics
Sandoz
Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Fierce Pharma
Wed, 07/10/19 - 11:34 am
Novartis
Mylan
Pfizer
EpiPens
Sandoz
Symjepi
drug launches
Adamis Pharmaceuticals
Sandoz launches oncology generic gefitinib in 13 EU countries
Pharmaceutical Business Review
Wed, 07/3/19 - 09:57 am
Sandoz
Novartis
generics
gefitinib
metastatic non-small cell lung cancer
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Fierce Pharma
Wed, 06/19/19 - 10:57 pm
Sanofi
bloodthinners
Lovenox
generics
Amphastar
Momenta
Sandoz
Novartis chief Vas Narasimhan wants you to know about the '25-plus’ blockbusters he has in the pipeline
Endpoints
Thu, 05/23/19 - 12:46 pm
Novartis
R&D
Sandoz
Pharma CEOs
Vas Narasimhan
Novartis' Sandoz does digital from back office to 'not just apps' therapeutics
Fierce Pharma
Tue, 05/14/19 - 05:04 pm
digital pharma
Sandoz
Novartis
Novartis vows to fight U.S. price-fixing claims against Sandoz unit
Yahoo/Reuters
Mon, 05/13/19 - 09:24 am
Novartis
Sandoz
generics
price fixing
Novartis Poaches GSK Veteran as New Sandoz CEO
BioSpace
Wed, 04/24/19 - 11:48 am
Novartis
Sandoz
generics
Pharma CEOs
Richard Saynor
GSK

Pages